European Archives - Page 258 of 1124 - European Medical Journal

Taking control of customer experience

The team explores how the industry may be missing out on insights from HCPs and hears from Robert Tegge, Associate Principal, ZS, who shares valuable insights on congresses.

Long-Term Immune Changes in Unvaccinated Patients with COVID-19

A study from Vienna reveals persistent immune changes, including shifts in cell counts and cytokine profiles, up to 10 months post-COVID-19 infection

Plant-Based Diets Uncover Rising Legume Allergies

Allergies to non-priority legumes like beans and chickpeas are increasing with the rise in plant-based diets. A new review highlights the need for more research on these allergens.

Interview: Michael Camilleri

One of the wonderful opportunities I’ve had over the years is to interact and go across specialties, divisions, or departments. Here at Mayo Clinic, there’s a wonderful legacy of cross-disciplinary research…

ESHRE 2024 Interview: Karen Sermon

I went to medical school in Brussels, but I knew very early on that I didn’t want to practice, I wanted to go into research. So, I looked…

Spotlight: July 2024

Catch up on the top pharma news stories of July in EMJ GOLD’s monthly round-up, including insights on pharma’s use of social media.

Long-Term Lung Damage Persists in COVID-19 Survivors

A recent study shows many COVID-19 survivors have lasting lung issues and reduced pulmonary function three years post-hospitalization, highlighting the need for ongoing care.

Donor Background Affects Stem Cell Transplant Success

Did you know that the socioeconomic background of a donor may affect the success of hematopoietic stem cell transplantation?

Multidisciplinary Approach Mitigates Refracture Risk for Adults with Hip Fracture

Refracture risk in adult patients who sustain a hip fracture can be mitigated through a new multidisciplinary approach, including fall prevention and anti-osteoporosis medication use.

Pregnancy Hope after Stem Cell Transplant

A new study from University Hospital Carl Gustav Carus, Dresden, Germany, has shed light on the viability of pregnancy following hematopoietic stem cell transplantation.